JPS5326327A - Medical composition active to central nerve system - Google Patents
Medical composition active to central nerve systemInfo
- Publication number
- JPS5326327A JPS5326327A JP8785277A JP8785277A JPS5326327A JP S5326327 A JPS5326327 A JP S5326327A JP 8785277 A JP8785277 A JP 8785277A JP 8785277 A JP8785277 A JP 8785277A JP S5326327 A JPS5326327 A JP S5326327A
- Authority
- JP
- Japan
- Prior art keywords
- medical composition
- central nerve
- nerve system
- composition active
- active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7622045A FR2358881A1 (en) | 1976-07-20 | 1976-07-20 | Neuroleptic compsn. contg. a gabamimetic potentiator - which is a benzylidene-amino-alkanoic acid deriv., for treating e.g. schizophrenia |
| FR7719390A FR2453643A2 (en) | 1977-06-24 | 1977-06-24 | PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5326327A true JPS5326327A (en) | 1978-03-11 |
Family
ID=26219550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8785277A Pending JPS5326327A (en) | 1976-07-20 | 1977-07-20 | Medical composition active to central nerve system |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS5326327A (en) |
| AU (1) | AU508753B2 (en) |
| CA (1) | CA1077846A (en) |
| DE (1) | DE2732614A1 (en) |
| GB (1) | GB1556567A (en) |
| IE (1) | IE45454B1 (en) |
| IL (1) | IL52550A (en) |
| LU (1) | LU77796A1 (en) |
| NL (1) | NL7708055A (en) |
| NZ (1) | NZ184666A (en) |
| SE (1) | SE7708349L (en) |
-
1977
- 1977-07-18 IL IL52550A patent/IL52550A/en unknown
- 1977-07-18 NZ NZ184666A patent/NZ184666A/en unknown
- 1977-07-19 LU LU77796A patent/LU77796A1/xx unknown
- 1977-07-19 SE SE7708349A patent/SE7708349L/en not_active Application Discontinuation
- 1977-07-19 IE IE1509/77A patent/IE45454B1/en unknown
- 1977-07-19 DE DE19772732614 patent/DE2732614A1/en not_active Withdrawn
- 1977-07-19 GB GB30355/77A patent/GB1556567A/en not_active Expired
- 1977-07-19 AU AU27151/77A patent/AU508753B2/en not_active Expired
- 1977-07-19 CA CA283,049A patent/CA1077846A/en not_active Expired
- 1977-07-20 NL NL7708055A patent/NL7708055A/en not_active Application Discontinuation
- 1977-07-20 JP JP8785277A patent/JPS5326327A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2715177A (en) | 1979-01-25 |
| NZ184666A (en) | 1980-04-28 |
| GB1556567A (en) | 1979-11-28 |
| IL52550A0 (en) | 1977-10-31 |
| IE45454L (en) | 1978-01-20 |
| IE45454B1 (en) | 1982-08-25 |
| NL7708055A (en) | 1978-01-24 |
| DE2732614A1 (en) | 1978-01-26 |
| SE7708349L (en) | 1978-01-21 |
| IL52550A (en) | 1981-03-31 |
| CA1077846A (en) | 1980-05-20 |
| LU77796A1 (en) | 1977-10-25 |
| AU508753B2 (en) | 1980-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS52114026A (en) | Pharmaceutical composition having antiiinflammation activity | |
| NZ183139A (en) | Medical electrodes | |
| AU511855B2 (en) | Skin treatment composition | |
| JPS52151712A (en) | Composition for medical preparation | |
| JPS52134026A (en) | Medical composition | |
| JPS5289700A (en) | Medical composition having antiiulcer activity | |
| GB2011368B (en) | Furface active composition | |
| GB1550707A (en) | Composition for relief of back pain | |
| IL56621A0 (en) | Novel electocatolytically active electrodes | |
| AU516933B2 (en) | Medicine with activity as prostaglandinsynthetase | |
| MY8000099A (en) | Isobutyramides, their preparation and therapeutic compositions containing them | |
| JPS5334930A (en) | Medical composition | |
| JPS5477489A (en) | Medical electrode | |
| JPS53142538A (en) | Active substance mixture | |
| JPS53121707A (en) | Agricultural medicine symmetrical nnsubstituted bisscarbamoyloxyiminodisulfide | |
| JPS5315428A (en) | Medical composition | |
| JPS5391131A (en) | Preparation for exterminating harmful organism | |
| JPS52148627A (en) | Medicine having antiiarrhythmia active prorerty | |
| ZA796896B (en) | Pharmaceutical composition having antitumor activity | |
| IL54745A (en) | Pharmaceutical compositions comprising active charcoal | |
| JPS5393683A (en) | Patient electrode | |
| JPS5326327A (en) | Medical composition active to central nerve system | |
| JPS5386039A (en) | Pharmaceutical composition having antiitumor activity | |
| ZA775603B (en) | Heart active compounds | |
| JPS52118426A (en) | Medical composition having selective histamineeh22acceptor stimulating activity |